NEW YORK (GenomeWeb) – Curetis today reported a 36 percent year-over year increase in revenues for the first half of 2018, largely due to sales of its diagnostic test cartridge and instruments in Europe, the Middle East, and Asia.

For the six-month period ended June 30, Curetis' revenues rose to €807,000 ($919,553) from €595,000 a year earlier. Contributing to the growth was a 257 percent surge in sales from cartridges and instruments in the EMEA market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.